Hartline Investment Corp Cuts Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Hartline Investment Corp lessened its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 5,396 shares of the exchange traded fund’s stock after selling 702 shares during the period. Hartline Investment Corp’s holdings in SPDR S&P Biotech ETF were worth $482,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently added to or reduced their stakes in XBI. Migdal Insurance & Financial Holdings Ltd. purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $102,900,000. Healthcare of Ontario Pension Plan Trust Fund grew its stake in SPDR S&P Biotech ETF by 103.3% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 1,771,000 shares of the exchange traded fund’s stock valued at $129,318,000 after purchasing an additional 900,000 shares during the last quarter. Employees Retirement System of Texas purchased a new position in SPDR S&P Biotech ETF in the third quarter valued at about $27,456,000. MBB Public Markets I LLC grew its stake in SPDR S&P Biotech ETF by 67.0% in the third quarter. MBB Public Markets I LLC now owns 514,411 shares of the exchange traded fund’s stock valued at $37,562,000 after purchasing an additional 206,337 shares during the last quarter. Finally, abrdn plc acquired a new stake in SPDR S&P Biotech ETF in the fourth quarter worth about $14,436,000.

SPDR S&P Biotech ETF Price Performance

NYSEARCA XBI traded down $0.75 during trading on Wednesday, hitting $83.94. The company’s stock had a trading volume of 8,780,125 shares, compared to its average volume of 11,706,246. The company has a market cap of $6.52 billion, a PE ratio of 11.47 and a beta of 1.08. The business’s 50 day simple moving average is $93.25 and its 200-day simple moving average is $84.57. SPDR S&P Biotech ETF has a fifty-two week low of $63.80 and a fifty-two week high of $103.52.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.